Cristina T Rosas

Summary

Affiliation: Cornell University
Country: USA

Publications

  1. ncbi Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?
    Cristina T Rosas
    Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA
    Expert Rev Vaccines 5:119-31. 2006
  2. ncbi Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies
    Cristina T Rosas
    Department of Microbiology and Immunology, Cornell University, Ithaca, NY 14853, USA
    Am J Trop Med Hyg 78:83-92. 2008
  3. ncbi A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus
    Gerlinde R Van De Walle
    The Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA
    Vaccine 28:1048-55. 2010
  4. ncbi Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins
    Cristina T Rosas
    Department of Microbiology and Immunology, Ithaca, NY 14853, USA
    J Gen Virol 88:748-57. 2007
  5. ncbi Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV)
    Cristina T Rosas
    Department of Microbiology and Immunology, Cornell University, Ithaca, NY 14853, USA
    Virus Res 125:69-78. 2007

Collaborators

Detail Information

Publications5

  1. ncbi Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?
    Cristina T Rosas
    Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA
    Expert Rev Vaccines 5:119-31. 2006
    ..The improvement of modified live virus vaccines will likely be a major focus of research in the future, and will hopefully help to more completely protect horses against one of the most important and devastating viral diseases...
  2. ncbi Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies
    Cristina T Rosas
    Department of Microbiology and Immunology, Cornell University, Ithaca, NY 14853, USA
    Am J Trop Med Hyg 78:83-92. 2008
    ....
  3. ncbi A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus
    Gerlinde R Van De Walle
    The Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA
    Vaccine 28:1048-55. 2010
    ....
  4. ncbi Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins
    Cristina T Rosas
    Department of Microbiology and Immunology, Ithaca, NY 14853, USA
    J Gen Virol 88:748-57. 2007
    ..Immunized animals presented with reduced viraemia levels and decreased nasal virus shedding, and maintained higher leukocyte counts than mock-vaccinated controls...
  5. ncbi Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV)
    Cristina T Rosas
    Department of Microbiology and Immunology, Cornell University, Ithaca, NY 14853, USA
    Virus Res 125:69-78. 2007
    ..From the results, we concluded that the EHV-1 vectored virus is able to express the WNV structural proteins and that vaccination of horses results in the induction of WNV E-protein-specific IgG(T), IgGb, and neutralizing antibodies...